Male Sexual
Wellness Improvement
By improving circulation, restoring muscle health and reducing inflammation users may experience improvement of sexual health wellness and function. Go from good to great! To be used under the supervision and guidance of a clinician only.
Male Sexual
Wellness Improvement
ErectiStim has developed a patent pending technology of precise bioelectric signaling designed for erectile dysfunction recovery. Our precision signals are directed towards controlling the release of these natural proteins.
Designed and intended to control expressions of these proteins
SDF-1 & PDGF for stem cell homing
IGF-1 & LIM for Nerve Regeneration
Follistatin & Klotho for muscle regeneration
EGF for Metabolic Syndrome Reversal
VEGF, PDGF, EGF, HIF1a, CXCL5, eNos and SDF1
for improving blood circulation
Increasing local blood circulation and muscle stimulation device - FDA 510K
ErectiStim Plus Lite™ MyoStim ED Biologics Clinical Study Protocol
MyoStim ED ErectiStim Endorses the SMSNA Position on Regulatory Pathway for Restorative Therapies for ED
An initial study on the effect of functional electrical stimulation in erectile dysfunction: a randomized controlled trial
ED affects approximately half of all men over age 40.
Important Papers
Click to download
MyoStim ED ErectiStimTM Bench Top Clinic Use High Fidelity
Precision Signal Stimulator
(U.S. FDA 510K K113017 cleared only for improving blood circulation, improved range of motion muscle
other labelling claims pending new 510K submission with new data)
MyoStim ED ErectiStim™
at home use portable bioelectric stimulator
(not available for sale investigational use only)
The therapy is delivered via a comfortable conductive wrap with bioelectric stimulation delivered as little a 7 to 20 minutes every other day for 12 weeks run from the comfort of your own home.
Cristiane Carboni
Chief Scientific Officer
MyoStim ED ErectiStim
An initial study on the effect of functional electrical stimulation in erectile dysfunction: a randomized controlled trial
Worldwide more than 330 million of men suffer from ED.
2% (aged 30 – 39 years)
10% (aged 40 – 49 years)
16% (aged 50 – 59 years)
34% (aged 60 – 69 years)
53% (aged 70 – 79 years)
Epidemiology of erectile dysfunction: results of the Cologne Male Survey.
In: Int J Impot Res
12 (2000), Nr. 6, S. 305–11
- Prevention or retardation of disuse atrophy
- Increase local blood circulation
- Muscle re-education
- Maintaining or increasing range of motion
- Saved special treatment protocols for each waveform (used for ErectiStim TM treatment).
- ErectiStim TM is investigational for the specific direct treatment of erectile dysfunction.
- ErectiStim is TM portable device is investigational at this time for all indications of use. One a new round of pre-clinical tests are done we will file to have cleared for improving circulation, treating inflammation/pain and muscle recovery but NOT erectile dysfunction. We will file for erectile dysfunction later for both the portable and bench top with more data to file with.